R9AP toggles between epithelial- and B-cell conformations to serve as EBVâ€™s universal receptor; dissecting gH/gL-R9AP structures across cell types will reveal how one receptor diversifies entry routes, exposing a conserved conformational switch as a pan-tropic therapeutic target.